HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Oncogenomics Researchers delve into the genetic foundations of cancer, focusing on the mutations and alterations within the genome that contribute to cancer development and progression. By sequencing the DNA of tumor cells, these specialists can pinpoint specific genetic changes that drive cancer's growth, such as mutations in oncogenes or tumor suppressor genes. Their research is integral in revealing how these genetic alterations can transform normal cells into malignant ones, aiding in the understanding of various cancer types at the molecular level.
These experts not only investigate the genetic causes of cancer but also work to translate their findings into clinical applications. Oncogenomics Researchers are involved in the development of targeted therapies, designed to specifically address the genetic abnormalities found in a patient’s cancer. They are also instrumental in identifying biomarkers that can improve early diagnosis, predict treatment responses, and track disease progression. By focusing on genetic factors, they enable more precise and personalized treatment plans that improve patient outcomes and reduce side effects. Their efforts also extend to studying the tumor microenvironment, providing a deeper understanding of how genetic changes interact with other factors to drive cancer progression. Additionally, their research is advancing our understanding of cancer resistance to treatment and recurrence. Oncogenomics Researchers are at the forefront of transforming cancer care, making treatments more effective, targeted, and individualized for each patient.
